Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism ABCG2 inhibitors(Broad substrate specificity ATP-binding cassette transporter ABCG2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC66H56N6O14 |
InChIKeyVCMDBWMGCBGSNR-UHFFFAOYSA-N |
CAS Registry2377858-65-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Preclinical | CN | 26 Sep 2019 |